RENVELA
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $25,664 | 8 | 1 |
| 2018 | $266.62 | 14 | 14 |
| 2017 | $132,149 | 2,266 | 1,246 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $79,829 | 10 | 50.5% |
| Food and Beverage | $40,183 | 2,244 | 25.4% |
| Travel and Lodging | $27,238 | 24 | 17.2% |
| Unspecified | $5,498 | 7 | 3.5% |
| Consulting Fee | $5,332 | 3 | 3.4% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease | GENZYME CORPORATION | $5,498 | 7 |
Top Doctors Receiving Payments for RENVELA — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Nephrology | Livonia, MI | $89.09 | 4 |
| , MD | Nephrology | Philadelphia, PA | $89.06 | 4 |
| , M.D | Nephrology | Orangeburg, SC | $88.65 | 6 |
| Dionicio Alvarez | Nephrology | El Paso, TX | $87.37 | 5 |
| , M.D | Nephrology | South Miami, FL | $87.27 | 5 |
| , MD | Nephrology | Miami, FL | $86.75 | 5 |
| , MD | Nephrology | Bellmore, NY | $86.51 | 4 |
| , M.D | Specialist | Monroe, NJ | $85.64 | 4 |
| , MD | Nephrology | Exton, PA | $85.62 | 4 |
| , MD | Nephrology | New York, NY | $85.35 | 4 |
| , M.D | Specialist | Houston, TX | $85.26 | 4 |
| , MD | Nephrology | Long Branch, NJ | $85.07 | 4 |
| , DO | Nephrology | Brick, NJ | $84.56 | 4 |
| , MD | Nephrology | South Miami, FL | $84.43 | 5 |
| , M.D | Nephrology | Murfreesboro, TN | $84.43 | 4 |
| , M.D | Student in an Organized Health Care Education/Training Program | Neptune, NJ | $83.21 | 4 |
| , MD | Internal Medicine | Trenton, NJ | $83.21 | 4 |
| , M.D | Nephrology | Memphis, TN | $82.89 | 5 |
| , M.D | Nephrology | Riverhead, NY | $78.86 | 4 |
| , M.D | Nephrology | San Jose, CA | $78.24 | 4 |
| , MD | Internal Medicine | Columbus, OH | $76.13 | 4 |
| , M.D | Nephrology | Kettering, OH | $76.04 | 5 |
| , M.D | Internal Medicine | Richland, WA | $75.96 | 5 |
| , MD | Nephrology | San Jose, CA | $75.50 | 4 |
| , M.D | Nephrology | Lawrence, MA | $74.17 | 4 |
Manufacturing Companies
- SANOFI-AVENTIS U.S. LLC $131,370
- GENZYME CORPORATION $26,710
Product Information
- Type Drug
- Total Payments $158,080
- Total Doctors 1,251
- Transactions 2,288
About RENVELA
RENVELA is a drug associated with $158,080 in payments to 1,251 healthcare providers, recorded across 2,288 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI-AVENTIS U.S. LLC.
Payment data is available from 2017 to 2019. In 2019, $25,664 was paid across 8 transactions to 1 doctors.
The most common payment nature for RENVELA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($79,829, 50.5% of total).
RENVELA is associated with 1 research study, including "Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease" ($5,498).